(Q53591434)
Statements
Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective. (English)
Alzahouri K
Lejeune C
Woronoff-Lemsi MC
Arveux P
Guillemin F
1 April 2005
60
4
479-492